Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -363,295 | -626,604 | -559,017 | -523,901 | -438,160 |
| Depreciation Amortization | 223,880 | 454,063 | 165,834 | 71,281 | 86,301 |
| Income taxes - deferred | -55,912 | -46,930 | -34,276 | 377 | 5,872 |
| Accounts receivable | 1,732 | -1,539 | -48,468 | -44,991 | -10,483 |
| Other Working Capital | 100,743 | -4,003 | -94,935 | -23,788 | 36,911 |
| Other Operating Activity | -14,836 | 66,595 | 214,208 | 269,690 | 125,488 |
| Operating Cash Flow | $-107,688 | $-158,418 | $-356,654 | $-251,332 | $-194,071 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -248 | -17,720 | 465,428 | 304,613 | -495,571 |
| PPE Investments | 21,554 | -28,438 | -32,016 | -28,213 | -17,843 |
| Net Acquisitions | N/A | N/A | N/A | -57,118 | N/A |
| Purchase Of Investment | -59,377 | -38,398 | -22,787 | -100 | -10,000 |
| Purchase Sale Intangibles | -67,747 | -92,181 | -120,444 | N/A | -38,134 |
| Other Investing Activity | 82,253 | -92,181 | -120,444 | 0 | -38,134 |
| Investing Cash Flow | $44,182 | $-176,737 | $290,181 | $219,182 | $-561,548 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 300,000 | N/A | 650,000 |
| Debt Repayment | -1,490 | -301,379 | -151,276 | -2,224 | -46,162 |
| Common Stock Issued | 33,764 | 29,994 | 71,082 | 23,101 | 103,574 |
| Other Financing Activity | 223,592 | 917,785 | -51,854 | 0 | -38,697 |
| Financing Cash Flow | $255,866 | $646,400 | $167,952 | $20,877 | $668,715 |
| Exchange Rate Effect | -7,328 | 3,114 | -2,772 | -7,821 | 7,688 |
| Beginning Cash Position | 610,284 | 295,925 | 197,218 | 216,312 | 295,528 |
| End Cash Position | 795,316 | 610,284 | 295,925 | 197,218 | 216,312 |
| Net Cash Flow | $185,032 | $314,359 | $98,707 | $-19,094 | $-79,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,688 | -158,418 | -356,654 | -251,332 | -194,071 |
| Capital Expenditure | -6,502 | -28,438 | -32,016 | -28,213 | -17,843 |
| Free Cash Flow | -114,190 | -186,856 | -388,670 | -279,545 | -211,914 |